Results in Fig. 7 indicate TGLI1 expression is positively linked to TEM7 expression in patient GBMs and also suggest that TGLI1 potentially contributes to poor clinical outcome of GBM patients through enhancing TEM7 expression, similarly to VEGF-C. The gene discussed is VEGFC; the disease is glioblastoma.